Garrett Brodeur

Garrett M. Brodeur is a distinguished pediatric oncologist and researcher at The Children's Hospital of Philadelphia (CHOP). He holds several important positions:

Professional Roles

• Professor of Pediatrics at the University of Pennsylvania's Perelman School of Medicine12
• Associate Chair for Research in the Department of Pediatrics at CHOP1
• Director of the Cancer Predisposition Program at CHOP12

Research Focus

Dr. Brodeur's research interests primarily revolve around:

• Neuroblastoma biology and genetics13
• Cancer predisposition syndromes24
• Targeted cancer therapy1
• Nanoparticle drug delivery4

Career Highlights

• Internationally recognized for his work on neuroblastoma, the most common solid tumor in childhood1
• Principal investigator or co-investigator on multiple NIH/NCI grants studying the genetic basis of neuroblastomas1
• Author of over 160 scientific papers and numerous textbook chapters1
• Organized the first AACR-sponsored International Workshop on Pediatric Cancer Predisposition and Surveillance in 20162

Education and Training

• MD from Washington University School of Medicine in St. Louis1
• Pediatric residency at St. Louis Children's Hospital1
• Fellowship in pediatric hematology-oncology at St. Jude's Children's Research Hospital1
• Postdoctoral fellowship in molecular genetics at Washington University1

Dr. Brodeur's work has significantly contributed to the understanding of neuroblastoma genetics and biology, as well as advancing the field of pediatric cancer predisposition. His research has led to important discoveries, such as the identification of activated ALK as the gene responsible for most cases of neuroblastoma predisposition.2